|

gemcitabine,nimotuzumab, toripalimab Clinical Trials

1 actively recruiting trial

Also known as: GNT

Pipeline

Phase 3: 1

Top Sponsors

  • Air Force Military Medical University, China1

Indications

  • Nasopharyngeal Carcinoma1
  • Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.